NCT06509906CompletedPhase 1
M9466 in Combination with Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Nov 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 5 Aug 2024
- Start date
- 8 Jan 2025
- Lead sponsor
- Merck Healthcare KGaA
- Diseases
- Colorectal cancer
- NCT number
- NCT06509906
- EU CT number
- 2024-514155-15-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 14
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Quirónsalud Barcelona Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital Universitario Quironsalud Madrid Coordinator of this site? Confirm its status | Pozuelo de Alarcón | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.